An avian cell line designed for production of highly attenuated viruses
- 1 January 2009
- Vol. 27 (5) , 748-756
- https://doi.org/10.1016/j.vaccine.2008.11.066
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Dendritic Cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivoBMC Immunology, 2008
- Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapyVaccine, 2007
- Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteersVaccine, 2006
- Modified vaccinia virus Ankara induces moderate activation of human dendritic cellsJournal of General Virology, 2004
- Smallpox vaccination and bioterrorism with pox virusesComparative Immunology, Microbiology and Infectious Diseases, 2003
- Detectionof reverse transcriptase activity in live attenuated virus vaccinesClinical and Diagnostic Virology, 1996
- A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virusVaccine, 1994
- Nonreplicating vaccinia vector efficiently expresses recombinant genes.Proceedings of the National Academy of Sciences, 1992
- Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulenceJournal of General Virology, 1991
- Regulation of the Interferon System: Evidence that Vero Cells have a Genetic Defect in Interferon ProductionJournal of General Virology, 1979